Literature DB >> 10081863

The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected.

G A Schuster1, T G Schuster.   

Abstract

PURPOSE: The relative amounts of epithelium, connective tissue, muscle and gland lumen in benign prostatic hyperplasia have been reported but they have not been correlated with prostate size. We determine if the relative amount of prostatic tissue varies with prostate size.
MATERIALS AND METHODS: Paraffin blocks of transurethrally resected prostate tissue were randomly chosen from the archives of 58 patients with benign prostatic hyperplasia. Two new slides per patient were made and stained with prostate specific antigen or Masson trichrome, respectively. A total of 20 images from each slide were captured using a high resolution camera, digitized and analyzed with computer software for the relative percentage of the various tissue components.
RESULTS: As the amount of prostate tissue resected increased from less than 10 to greater than 70 gm. the epithelium had a 4-fold increase from 5.37 to 21.92%, the muscle component had a 42% decrease from 28.46 to 16.62%, the lumen doubled from 7.05 to 14.01% and the connective tissue remained relatively unchanged from 35.58 to 31.53%. There was a statistically significant difference in all components of prostatic tissue except for connective tissue when comparing prostates less than 30 versus greater than 30 gm., including epithelium 6.52 versus 16.10% (p <0.01), muscle 28.45 versus 20.78% (p <0.01), lumen 7.42 versus 14.58% (p <0.01) and connective tissue 35.74 versus 32.45% (p <0.06). The stroma-to-epithelium and muscle-to-epithelium ratios each had a 9-fold decline (p = 0.01).
CONCLUSIONS: As the prostate increases in size, there is statistically significant more epithelium and lumen, and less muscle tissue.

Entities:  

Mesh:

Year:  1999        PMID: 10081863

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

Review 2.  Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

Authors:  Kalyan J Gangavarapu; Peter F Jowdy; Barbara A Foster; Wendy J Huss
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

3.  PSA density is associated with BPH cellular composition.

Authors:  Liwei Jia; Douglas W Strand; Ramy S Goueli; Jeffrey C Gahan; Claus G Roehrborn; Ryan J Mauck
Journal:  Prostate       Date:  2022-06-02       Impact factor: 4.012

Review 4.  The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Authors:  Xun Fu; Huan Liu; Jiang Liu; Michael E DiSanto; Xinhua Zhang
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

Review 5.  3D Printed Organ Models for Surgical Applications.

Authors:  Kaiyan Qiu; Ghazaleh Haghiashtiani; Michael C McAlpine
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2018-03-28       Impact factor: 10.745

6.  3D Printed Organ Models with Physical Properties of Tissue and Integrated Sensors.

Authors:  Kaiyan Qiu; Zichen Zhao; Ghazaleh Haghiashtiani; Shuang-Zhuang Guo; Mingyu He; Ruitao Su; Zhijie Zhu; Didarul B Bhuiyan; Paari Murugan; Fanben Meng; Sung Hyun Park; Chih-Chang Chu; Brenda M Ogle; Daniel A Saltzman; Badrinath R Konety; Robert M Sweet; Michael C McAlpine
Journal:  Adv Mater Technol       Date:  2017-12-06

Review 7.  Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.

Authors:  Akhilesh Prajapati; Sharad Gupta; Bhavesh Mistry; Sarita Gupta
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.